Cargando…
Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature
SIMPLE SUMMARY: Hepatocellular carcinoma is the third most prevalent cancer world-wide. This study aimed to reveal the metabolic signature of hepatocellular carcinoma compared to adjacent normal liver cells. To achieve this, metabolites were detected, analyzed, and quantified using targeted and non-...
Autores principales: | Tambay, Vincent, Raymond, Valérie-Ann, Goossens, Corentine, Rousseau, Louise, Turcotte, Simon, Bilodeau, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296227/ https://www.ncbi.nlm.nih.gov/pubmed/37370840 http://dx.doi.org/10.3390/cancers15123232 |
Ejemplares similares
-
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
por: Tambay, Vincent, et al.
Publicado: (2021) -
Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma
por: Cassim, Shamir, et al.
Publicado: (2018) -
Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes
por: Lacoste, Benoit, et al.
Publicado: (2016) -
Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties
por: Lacoste, Benoit, et al.
Publicado: (2017) -
Distinct Metabolomic Signatures Are Associated with Longevity in Humans
por: Cheng, Susan, et al.
Publicado: (2015)